Literature DB >> 14743354

Surgery in Tourette syndrome.

Yasin Temel1, Veerle Visser-Vandewalle.   

Abstract

Tourette syndrome (TS) is a neuropsychiatric disorder with onset in early childhood. It is characterized by tics and often accompanied by disturbances in behavior, such as obsessive-compulsive disorder (OCD). In most cases, the disorder is self-limited or can be treated by medication or behavioral therapy. In a small percentage, however, symptoms are intractable to any conservative treatment. Since 1955, various attempts have been made to treat these patients through neurosurgical procedures. The target sites have been diverse and include the frontal lobe (prefrontal lobotomy and bimedial frontal leucotomy), the limbic system (limbic leucotomy and anterior cingulotomy), the thalamus, and the cerebellum. Combined approaches have also been tried such as anterior cingulotomies plus infrathalamic lesions. The results have often been unsatisfactory or major side effects have occurred, such as hemiplegia or dystonia. Our review of the literature from 1960 until 2003 revealed 21 reports and 3 descriptions in textbooks covering about 65 patients in total who had undergone ablative procedures for intractable TS, the first being reported in 1962. In 1999, deep brain stimulation (DBS) was introduced as a new approach for intractable TS. To date, 3 patients have been reported who underwent bilateral thalamic stimulation, with promising results on tics and obsessive-compulsive symptoms. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Year:  2004        PMID: 14743354     DOI: 10.1002/mds.10649

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  42 in total

1.  Neurosurgical interventions for neuropsychiatric syndromes.

Authors:  C Alan Anderson; David B Arciniegas
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

Review 2.  Advances in understanding and treatment of Tourette syndrome.

Authors:  Kevin St P McNaught; Jonathan W Mink
Journal:  Nat Rev Neurol       Date:  2011-11-08       Impact factor: 42.937

3.  Long-term habituation of the smile response with deep brain stimulation.

Authors:  Utaka S Springer; Dawn Bowers; Wayne K Goodman; Nathan A Shapira; Kelly D Foote; Michael S Okun
Journal:  Neurocase       Date:  2006-06       Impact factor: 0.881

Review 4.  Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.

Authors:  Atchar Sudhyadhom; Frank J Bova; Kelly D Foote; Christian A Rosado; Lindsey Kirsch-Darrow; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

5.  Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys.

Authors:  Jose L Lanciego; Maria C Rodríguez-Oroz; Francisco J Blesa; Lydia Alvarez-Erviti; Jorge Guridi; Pedro Barroso-Chinea; Yoland Smith; Jose A Obeso
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

Review 6.  Deep brain stimulation for psychiatric disorders.

Authors:  Paul Sloan Larson
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 7.  Deep brain stimulation: current and future clinical applications.

Authors:  Mark K Lyons
Journal:  Mayo Clin Proc       Date:  2011-06-06       Impact factor: 7.616

8.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

Review 9.  Pediatric indications for deep brain stimulation.

Authors:  Matthew F DiFrancesco; Casey H Halpern; Howard H Hurtig; Gordon H Baltuch; Gregory G Heuer
Journal:  Childs Nerv Syst       Date:  2012-07-25       Impact factor: 1.475

10.  Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome.

Authors:  Yuko Kataoka; Paul S A Kalanithi; Heidi Grantz; Michael L Schwartz; Clifford Saper; James F Leckman; Flora M Vaccarino
Journal:  J Comp Neurol       Date:  2010-02-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.